SearchSearch results for: “”

Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.

Stibbe represented the bankruptcy trustees of  the Amsterdam hospital MC Slotervaart in proceedings against the City of Amsterdam, centred on the City’s demand that the bankruptcy trustees investigate whether there were any irregularities prior to the ban

Stibbe advises Excesss Materials Exchange, a digital facilitated marketplace B2B platform for excess materials trade, on legal matters including setting up the articles of association, structure, employment law, data protection, and defining "waste".

Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.

Stibbe advises Hardt on legal aspects in relation to the development of the Hyperloop technology.

Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland).

Stibbe advised the metropolitan region of Rotterdam and The Hague (MRDH) on a loan of EUR 115 million to companies EBS (13.4 million) and RET (102 million) to buy buses for the concessions Voorne-Putten and Rozenburg and Bus Rotterdam.

Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.

Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon.

Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist).

Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. 

Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 

Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million.